Rezolute (RZLT) Change in Inventory (2014 - 2015)
Rezolute (RZLT) posted Change in Inventory of $119540.0 for Q3 2015, up 574.23% sequentially from -$25207.0 in Q2 2015, and up 871.71% YoY from $12302.0 in Q3 2014.
Powered by 
Analysis
Rezolute (RZLT) Change in Inventory (2014 - 2015) Analysis & Trends
Rezolute has reported Change in Inventory for 2 years, with the latest figure at $119540.0 in Q3 2015.
- Quarterly Change in Inventory rose 871.71% year-over-year to $119540.0 in Q3 2015, while the trailing twelve-month figure through Sep 2015 was -$115144.0 (down 245.93% YoY) and the FY2015 annual result came in at -$222382.0, down 433.91% from the prior year.
- Change in Inventory climbed to $119540.0 in Q3 2015 per RZLT's latest filing, from -$25207.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $119540.0 in Q3 2015 and troughed at -$225767.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 132.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 47.15 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -280,000.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2015 | 119,540.00 |
| Jun 30, 2015 | -25,207.00 |
| Mar 31, 2015 | 16,290.00 |
| Dec 31, 2014 | -225,767.00 |
| Sep 30, 2014 | 12,302.00 |
| Jun 30, 2014 | 66,600.00 |